Anti‐tuberculous therapy for maintenance of remission in Crohns disease

机译：维持克罗恩病缓解的抗结核疗法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundThere have been a number of studies with conflicting results which have examined the effect of anti‐tuberculous therapy in Crohn's disease. A meta‐analysis was performed to evaluate the use of anti‐tuberculous therapy for the maintenance of remission in Crohn's disease.

机译：背景已有许多研究结果相互矛盾，研究了抗结核疗法在克罗恩病中的作用。进行了荟萃分析，以评估抗结核疗法在克罗恩病缓解中的维持作用。

著录项

期刊名称 The Cochrane Database of Systematic Reviews
作者
Petrease H Patton; Claire E Parker; John K MacDonald; Nilesh Chande;
展开▼
作者单位

展开▼
年(卷),期 -1(2016),7
年度 -1
页码 CD000299
总页数 31
原文格式 PDF
正文语种
中图分类基础医学;
关键词
Humans Secondary Prevention Antitubercular Agents Antitubercular Agents/adverse effects Antitubercular Agents/therapeutic use Clarithromycin Clarithromycin/therapeutic use Clofazimine Clofazimine/therapeutic use Crohn Disease Crohn Disease/drug therapy Crohn Disease/prevention control Ethambutol Ethambutol/therapeutic use Glucocorticoids Glucocorticoids/therapeutic use Maintenance Chemotherapy Maintenance Chemotherapy/methods Methylprednisolone Methylprednisolone/therapeutic use Prednisone Prednisone/therapeutic use Randomized Controlled Trials as Topic Recurrence Remission Induction Rifabutin Rifabutin/therapeutic use Rifampin Rifampin/therapeutic use;

机译：人类;二级预防;抗结核药;抗结核药/不良反应;抗结核药/治疗用途;克拉霉素;克拉霉素/治疗用途;氯法嗪明;氯法齐明/治疗用途;克罗恩病;克罗恩病/药物治疗;克罗恩病/预防和控制;乙胺丁醇;乙胺丁醇/治疗用途;糖皮质激素;糖皮质激素/治疗用途;维持化学疗法;维持化学疗法/方法;甲基泼尼松龙;甲基泼尼松龙/治疗用途;泼尼松;泼尼松/治疗;缓解率;瑞法汀;随机对照试验/治疗用途;利福平;利福平/治疗用途;

相似文献

外文文献
中文文献
专利

1. Systematic Review and Meta-analysis: Adalimumab Monotherapy Versus Combination Therapy with Immunomodulators for Induction and Maintenance of Remission and Response in Patients with Crohn's Disease [J] . Chalhoub Jean M., Rimmani Hussein H., Gumaste Vivek V., Inflammatory bowel diseases . 2017,第8期

机译：系统评价和荟萃分析：Adalimumab单疗法与免疫调节剂的联合治疗诱导和维持克罗恩病患者的缓解和响应
2. Monotherapy With Infliximab Versus Combination Therapy in the Maintenance of Clinical Remission in Children With Moderate to Severe Crohn Disease [J] . Kierkus Jaroslaw, Iwanczak Barbara, Wegner Agnieszka, Journal of pediatric gastroenterology and nutrition . 2015,第5期

机译：英夫利昔单抗与联合疗法的单药治疗维持中度至严重克罗恩病患儿的临床缓解
3. Combination therapy with adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn's disease patient with the loss of response to scheduled adalimumab maintenance therapy: A case report [J] . OzekiK., TanidaS., MizushimaT., Internal medicine. . 2012,第6期

机译：阿达木单抗联合强化粒细胞和单核细胞单采血液分离术治疗克罗恩病患者的临床缓解，但对预定的阿达木单抗维持治疗无反应：一例病例报告
4. A new concept of inducing remission in Crohn's disease: anti-interleukin-2-receptor antibody and mycophenolate mofetil [C] . M. LYONS, R. GANSCHOW, A. VENZKE, Falk Symposium . 2002

机译：克罗恩疾病中诱导缓解的新概念：抗白细胞介素-2-受体抗体和霉酚酸酯
5. Efficacy of Pharmacological Agents on The Remission Induction and Maintenance of Crohn’s Disease [D] . Farooq, Jeffrey 2019

机译：药理剂对克罗恩病减产和维持的疗效
6. A134 ANTI-IL-12/23P40 ANTIBODIES FOR MAINTENANCE OF REMISSION IN CROHN’S DISEASE [O] . S C Davies, T Nguyen, J MacDonald, 2018

机译：A134抗IL-12 / 23P40抗体用于维持克罗恩病的缓解
7. DOP064. Predictors of disease relapse of patients with Crohn's disease in Deep Remission: Who and when can withdraw thiopurine maintenance therapy? [O] . 2015

机译：DOP064。乳酸疾病患者疾病复发预测因素深处患者：谁和何时可以撤回硫嘌呤维持治疗？

Anti‐tuberculous therapy for maintenance of remission in Crohns disease

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅